VXRT
Vaxart Inc
Price:  
0.32 
USD
Volume:  
24,017,526.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

VXRT EV/EBITDA

268.7%
Upside

As of 2025-12-15, the EV/EBITDA ratio of Vaxart Inc (VXRT) is -1.08. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. VXRT's latest enterprise value is 51.86 mil USD. VXRT's TTM EBITDA according to its financial statements is -48.24 mil USD. Dividing these 2 quantities gives us the above VXRT EV/EBITDA ratio.

Range Selected
Trailing P/E multiples 13.9x - 15.0x 14.9x
Forward P/E multiples 18.9x - 34.2x 21.4x
Fair Price (2.68) - 8.33 1.18
Upside -937.8% - 2502.4% 268.7%
0.32 USD
Stock Price
1.18 USD
Fair Price

VXRT EV/EBITDA - Historical EV/EBITDA Data

Date EV/EBITDA
2025-12-12 -1.32
2025-12-11 -1.30
2025-12-10 -1.29
2025-12-09 -1.30
2025-12-08 -1.30
2025-12-05 -1.29
2025-12-04 -1.32
2025-12-03 -1.28
2025-12-02 -1.37
2025-12-01 -1.37
2025-11-28 -1.32
2025-11-26 -1.27
2025-11-25 -1.23
2025-11-24 -1.28
2025-11-21 -1.30
2025-11-20 -1.36
2025-11-19 -1.42
2025-11-18 -1.44
2025-11-17 -1.42
2025-11-14 -1.50
2025-11-13 -1.30
2025-11-12 -1.29
2025-11-11 -1.33
2025-11-10 -1.46
2025-11-07 -1.51
2025-11-06 -1.37
2025-11-05 -1.12
2025-11-04 -1.15
2025-11-03 -1.12
2025-10-31 -1.15
2025-10-30 -1.23
2025-10-29 -1.23
2025-10-28 -1.22
2025-10-27 -1.27
2025-10-24 -1.29
2025-10-23 -1.29
2025-10-22 -1.23
2025-10-21 -1.28
2025-10-20 -1.25
2025-10-17 -1.27
2025-10-16 -1.25
2025-10-15 -1.22
2025-10-14 -1.19
2025-10-13 -1.17
2025-10-10 -1.21
2025-10-09 -1.22
2025-10-08 -1.19
2025-10-07 -1.23
2025-10-06 -1.27
2025-10-03 -1.29